https://www.neurologylive.com/view/ocrelizumab-impact-on-humoral-response-to-ebv-robert-zivadinov
0
0
11/1/22 at 6:12pm
Organization
Neurologylive.com
The director of the Buffalo Neuroimaging Analysis Center provided context on a new study exploring ocrezliumab’s (Ocrevus; Genentech) effect on leptomeningeal inflammation and humoral response to EBV. [WATCH TIME: 5 minutes]
Create an account
or login to join the discussion